BioSpace News Archive

Tonix Pharmaceuticals Holding Corp. today announced the U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug (IND) Application to support the initiation of a Phase 2 study of TNX-1900* (intranasal potentiated oxytocin) for the prevention of migraine headache in chronic migraineurs.

XORTX Therapeutics Inc. announces that it will hold its annual and special meeting of shareholders at 11:00 a.m. (Calgary time) on Monday, December 20, 2021.

Qilian International Holding Group Limited today announced that Gan Di Xin® and Qilian Shan® Oxytetracycline, products of the Company’s subsidiary, Gansu Qilianshan Pharmaceutical Co., Ltd. (“Gansu QLS”), have been included in the List for Development of Leading Enterprises with Large Varieties and Brands of Pharmaceuticals of Gansu Province (the “List”).

Merchants utilizing Shift4Shop’s turnkey e-commerce platform can help their customers’ online purchases mean more this holiday shopping season. Customers can now donate to St. Jude Children’s Research Hospital.

Kura Oncology, Inc., a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, announced that Troy Wilson, Ph.D., J.D., President and Chief Executive Officer, is scheduled to participate in two upcoming virtual investor conferences.

Novocure (NASDAQ: NVCR) announced today it will participate in two upcoming investor conferences.

Promore Pharma releases it’s Interim Report January - September 2021.

Motus GI Holdings, Inc. announced today that its management team is scheduled to present at two upcoming investor conferences in December 2021.

The global plasma fractionation market is envisaged to develop at a brisk pace owing to the rising geriatric population all over the world.

Medical imaging has made tremendous strides on the back two pillars: continuous technological advancements and the sheer pace of digital transformation in radiology.